Showing Results for: “Contact ”

Safe at School: Ohio

The diabetes medications glimepiride and linagliptin had similar impacts on cardiovascular morbidity and mortality for a median period of 6.3 years, when added to standard care for people with relatively early type 2 diabetes (T2D), many of whom had an elevated risk of cardiovascular disease (CVD) or existing CVD at the beginning of the study, according to research presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. The study was featured today at “The CAROLINA Trial—First Results of the Cardiovascular

In a study measuring Beta-cell (β-cell) function in adults with impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes (T2D), researchers from the Restoring Insulin Secretion (RISE) Adult Medication Study found β-cell function was improved during active treatment but did not produce any lasting benefits after treatment cessation. Results presented today at a symposium at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® suggest continued intervention may be required to alter progressive β-cell dysfunction. Given the increased recognition of the critical role

Pancreatic beta cells that do not produce sufficient insulin in people with type 2 diabetes (T2D) are not permanently damaged during the early stages of the disease and can be restored to normal function through the removal of excess fat in the cells, according to a study entitled “Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®. More than one-third (36%) of the participants who took part in an

In a comparison of two different diet and two different weight management programs, results of the international PREVIEW intervention study found a low, similar rate of progression to type 2 diabetes (T2D) among people with prediabetes who had initially lost weight on a low-calorie diet (LCD), according to a symposium presentation today titled “PREVIEW Study Results—Prevention of Diabetes through Lifestyle Intervention and Population Studies Around the World” at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® in San Francisco. The study showed no difference between

Improvements in Vision Impairment and Diabetes Plateaued in the Last Decade A Centers for Disease Control and Prevention (CDC) study provides new insights into vision impairment (VI) prevalence over the last 20 years. The findings demonstrate that declines in VI among adults with diabetes seen in the first decade of the 2000s may have plateaued in 2012. The findings were presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans, LA. Diabetic retinopathy is a common and serious complication of diabetes that occurs when blood vessels in the retina are

Leading diabetes researchers and clinicians from around the world highlight impact of pandemic on patient outcomes and key learnings The American Diabetes Association ® (ADA) is kicking off the virtual 81st Scientific Sessions tomorrow and will feature five COVID-19 Symposia, highlighting cutting-edge science and the latest diabetes developments learned during the initial phases of the pandemic. The Symposia will be presented over the course of the annual meeting taking place June 25–29. This latest research comes at a time when individuals with diabetes, and other related underlying health

People with diabetes are three times as likely to need hospitalization if infected with COVID-19 With the diabetes community at greater risk for complications during the COVID-19 pandemic, the American Diabetes Association® (ADA) and Sun Life partnered to reinvent this year’s annual Call to Congress to educate advocates on COVID-19 and diabetes, and how to support people with diabetes during the pandemic. Usually an in-person gathering of ADA Advocates on Capitol Hill, the recent virtual town hall event informed and engaged the diabetes advocate community about legislative goals specific to

With diabetes, protect your foot health by learning how to prevent foot complications, recognize warning signs early, and practice daily care to reduce the risk of ulcers, infections, and amputation.